PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
VERV vs. EDIT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

VERV vs. EDIT

Last updated May 11, 2025

Compare and contrast key facts about Verve Therapeutics, Inc. (VERV) and Editas Medicine, Inc. (EDIT).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VERV or EDIT.

Correlation

The correlation between VERV and EDIT is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

VERV vs. EDIT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verve Therapeutics, Inc. (VERV) and Editas Medicine, Inc. (EDIT). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

VERV:

-0.35

EDIT:

-0.58

Sortino Ratio

VERV:

0.10

EDIT:

-0.89

Omega Ratio

VERV:

1.01

EDIT:

0.90

Calmar Ratio

VERV:

-0.33

EDIT:

-0.75

Martin Ratio

VERV:

-1.08

EDIT:

-1.32

Ulcer Index

VERV:

28.90%

EDIT:

56.44%

Daily Std Dev

VERV:

95.32%

EDIT:

128.13%

Max Drawdown

VERV:

-95.99%

EDIT:

-98.92%

Current Drawdown

VERV:

-94.28%

EDIT:

-98.40%

Fundamentals

Market Cap

VERV:

$377.08M

EDIT:

$121.38M

EPS

VERV:

-$2.35

EDIT:

-$2.88

PS Ratio

VERV:

11.66

EDIT:

3.76

PB Ratio

VERV:

0.76

EDIT:

0.90

Total Revenue (TTM)

VERV:

$26.64M

EDIT:

$31.18M

Gross Profit (TTM)

VERV:

$21.52M

EDIT:

$26.78M

EBITDA (TTM)

VERV:

-$166.70M

EDIT:

-$164.01M

Returns By Period

In the year-to-date period, VERV achieves a -25.00% return, which is significantly lower than EDIT's 14.17% return.

VERV

YTD

-25.00%

1M

38.69%

6M

-32.96%

1Y

-29.62%

5Y*

N/A

10Y*

N/A

EDIT

YTD

14.17%

1M

30.63%

6M

-53.53%

1Y

-72.74%

5Y*

-44.56%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Risk-Adjusted Performance

VERV vs. EDIT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
VERV
The Risk-Adjusted Performance Rank of VERV is 3333
Overall Rank
The Sharpe Ratio Rank of VERV is 3333
Sharpe Ratio Rank
The Sortino Ratio Rank of VERV is 4040
Sortino Ratio Rank
The Omega Ratio Rank of VERV is 3939
Omega Ratio Rank
The Calmar Ratio Rank of VERV is 3131
Calmar Ratio Rank
The Martin Ratio Rank of VERV is 2424
Martin Ratio Rank
EDIT
The Risk-Adjusted Performance Rank of EDIT is 1414
Overall Rank
The Sharpe Ratio Rank of EDIT is 2020
Sharpe Ratio Rank
The Sortino Ratio Rank of EDIT is 1515
Sortino Ratio Rank
The Omega Ratio Rank of EDIT is 1717
Omega Ratio Rank
The Calmar Ratio Rank of EDIT is 77
Calmar Ratio Rank
The Martin Ratio Rank of EDIT is 1313
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VERV vs. EDIT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Verve Therapeutics, Inc. (VERV) and Editas Medicine, Inc. (EDIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current VERV Sharpe Ratio is -0.35, which is higher than the EDIT Sharpe Ratio of -0.58. The chart below compares the historical Sharpe Ratios of VERV and EDIT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading data...

Dividends

VERV vs. EDIT - Dividend Comparison

Neither VERV nor EDIT has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

VERV vs. EDIT - Drawdown Comparison

The maximum VERV drawdown since its inception was -95.99%, roughly equal to the maximum EDIT drawdown of -98.92%. Use the drawdown chart below to compare losses from any high point for VERV and EDIT. For additional features, visit the drawdowns tool.

Loading data...

Volatility

VERV vs. EDIT - Volatility Comparison

Verve Therapeutics, Inc. (VERV) has a higher volatility of 42.74% compared to Editas Medicine, Inc. (EDIT) at 31.19%. This indicates that VERV's price experiences larger fluctuations and is considered to be riskier than EDIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading data...

Financials

VERV vs. EDIT - Financials Comparison

This section allows you to compare key financial metrics between Verve Therapeutics, Inc. and Editas Medicine, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

0.0010.00M20.00M30.00M40.00M50.00M60.00MAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
13.08M
30.60M
(VERV) Total Revenue
(EDIT) Total Revenue
Values in USD except per share items